| Date | Title | Description |
| 16.08.2012 | U.K. regulators want more data on Smith & Nephew’s Exogen bone healing system | British orthopedic devices maker Smith & Nephew (FTSE:SN, NYSE:SNN) will need to provide more information on its Exogen bone-healing system before getting the green light for use in all fractures, U.K. regulators said.
The National Inst... |
| 12.04.2012 | Smith & Nephew adds Baroness Bottomley to board of directors | Personnel Moves | British orthopedic giant Smith & Nephew (NYSE:SNN) added former Parliament member and conservative politician Baroness Virginia Bottomley of Nettlestone to its board of directors.
Bottomley served in the U.K.’s House of Commons from 198... |
| 02.04.2012 | Boston Scientific launches Pluromed’s BackStop kidney stone treatment | Wall Street Beat | Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.
Boston licenses the BackStop product, a polymer gel plug injected into the ureter via catheter to pre... |
| 13.03.2012 | Hip Study: Smith & Nephew touts study results for new metal-on-metal implants | British orthopedic titan Smith & Nephew (NYSE:SNN) touted the results of a 10-year study of its metal-on-metal hip resurfacing implants, hoping to differentiate its implants from the high-profile recall of rival DePuy’s ASR device.
Smit... |
| 06.02.2012 | Smith & Nephew pays $22M fine for 10 years of bribery in Greece | British orthopedic titan Smith & Nephew (NYSE:SNN) must pay $22.2 million to settle charges of bribing Greek doctors for more than a decade, according to SEC documents.
The complaint alleges that Smith & Nephew subsidiaries used a d... |
| 06.01.2012 | SonoSite CFO resigns, makes $3M | Personnel Moves | SonoSite (NSDQ:SONO) CFO Marcus Smith stands to pull down more than $3 million now that he’s retired from the Bothell, Wash.-based ultrasound device maker.
The company said Smith’s resignation, which went into effect yesterday, was to pursu... |
| 05.01.2012 | Smith & Nephew spins off N.C. biologics unit into joint venture Bioventus | Smith & Nephew operates three global divisions: Advanced Surgical Devices, Advanced Wound Management, and Biologics & Clinical Therapies. The Biologics & Clinical Therapies division is focused on less invasive treatments compare... |
| 04.01.2012 | SNN spins out biologics unit in JV with Essex Woodlands | British orthopedic titan Smith & Nephew (NYSE:SNN) shuffled its business deck yet again with the spinout of its biologics and clinical therapies division in a joint venture with venture capital firm Essex Woodlands.
Essex will own 51% o... |
| 04.11.2011 | Smith & Nephew falls on softer orthopedic margins | Earnings Roundup | Lower margins for Smith & Nephew’s (NYSE:SNN) bread-and-butter orthopedics division drove the British company’s third-quarter profits down nearly 3 percent for the three months ended Oct. 1.
Smith & Nephew posted profits of $133 mil... |
| 04.11.2011 | Smith & Nephew falls on softer orthopedic margins | Lower margins for Smith & Nephew’s (NYSE:SNN) bread-and-butter orthopedics division drove the British company’s third-quarter profits down nearly 3 percent for the three months ended Oct. 1.
Smith & Nephew posted profits of $133 mil... |
| 31.10.2011 | Four barriers stifling medical device innovation | “I think it will be,” he said. “But it will be very different.”
Augusti is the president of London based Smith & Nephew’s biologics division, which is located in Durham, North Carolina. Last Friday, Augusti spoke at the BioSciences Foru... |
| 05.08.2011 | Smith & Nephew realignment plan targets growth in emerging markets | At the same time, SNN will create a new division to focus solely on what Bouhon called the more established emerging markets of Brazil, Russia, India and China. This division will have some autonomy in that it will sell the company’s full s... |
| 05.08.2011 | Smith & Nephew’s BRIC business to grow five-fold in next five years | British orthopedic giant Smith & Nephew plc (NYSE:SNN) announced an ambitious plan to realign the entire company to focus growth on the emerging markets of Brazil, Russia, India and China, while creating a more streamlined operation in ... |
| 26.07.2011 | Smith & Nephew: Restructuring of orthopedic business will free up resources for BRIC markets | British orthopedic giant Smith & Nephew plc (NYSE:SNN) is shuffling the deck in order to focus on higher growth markets in Brazil, Russia, India and China, according to a company spokesman.
Late yesterday news began trickling out that S... |
| 19.04.2011 | NC biotech strikes deal to launch new blood clotting bandage | The Stasilon bandage itself received Food and Drug Administration clearance in 2007. Entegrion had been trying to commercialize the product on its own. But those efforts were stymied by the financial markets.
Now, though, Entegrion has rais... |
| 19.01.2011 | The zombie deal that won’t die: Smith & Nephew | No matter how many times Smith & Nephew (NYSE:SNN) says it’s not talking merger, somebody else says it is.
The U.K.-based device manufacturer sought to tamp down several days of speculation late last week that it was close to a deal wit... |
| 19.11.2010 | KCI wins one in war with Smith & Nephew | A British appeals court upheld a decision finding that Smith & Nephew Group plc (NYSE:SNN) infringes two patents licensed to Kinetic Concepts Inc. (NYSE:KCI) in their long-running war over negative-pressure wound therapy.
The donnybrook... |
| 19.10.2010 | KCI loses a round in NPWT war with Smith & Nephew | The latest round in a long-running battle over negative-pressure wound therapy patents went to Smith & Nephew plc (NYSE:SNN), after a Texas judge’s ruling that some claims in a pair of Kinetic Concepts Inc. (NYSE:KCI) patents are invali... |
| 16.08.2010 | SNN, KCI split German court ruling over NPWT patent | A German court issues a split decision in a patent infringement lawsuit between Smith & Nephew plc and Kinetic Concepts Inc. over negative-pressure wound therapy.
A German court handed down a split decision in the long-running patent ba... |
| 03.08.2010 | Smith & Nephew appeal in patent fight with KCI slated for October | After recently picking up a British court victory, Kinetic Concepts Inc. (NYSE:KCI) and Smith & Nephew Group plc (NYSE:SNN) are heading back to court in October in their long-running fight over who can legally market negative-pressure w... |
| 25.06.2010 | British court deals Smith & Nephew a setback in NPWT war with Kinetic Concepts | A British court dealt Smith & Nephew plc (NYSE:SNN) a blow in its long-running patent infringement war with Kinetic Concepts Inc. (NYSE:KCI), ruling that two of Smith & Nephew’s Renasys negative-pressure wound therapy devices infrin... |
| 10.03.2010 | Jury rules for KCI in NPWT spat with Smith & Nephew | A Texas jury handed a win to Kinetic Concepts Inc. (NYSE:KCI) in its wound care war with Smith & Nephew (NYSE:SNN), ruling that the British medical products conglomerate infringed a pair of KCI-licensed patents with its Renasys-F negati... |
| 03.02.2010 | CardioInsight Technologies closes $6M investment round for heart-mapping technology | CardioInsight’s electrocardiographic mapping technology gathers electrical information about the heart from an electrode “vest” placed on a patient’s body and combines that information with images from a CT scan to produce 3-D maps of t... |
| 03.02.2010 | CardioInsight wraps up $6 million | By Mary Vanac
CLEVELAND, Ohio — CardioInsight Technologies closed its second funding round, raising $6 million from new and existing investors to speed up and expand testing and commercialization of its heart-mapping technology.
Existing in... |
| 20.01.2010 | CardioInsight raises $5.7M for heart-mapping technology | CardioInsight got its start in 2006 with $750,000 in funding from Draper Triangle Ventures, the Pittsburgh office of Midwestern venture capital fund Draper Fisher Jurvetson, JumpStart Inc., the nonprofit venture development organization... |
| 20.01.2010 | CardioInsight raises $5.7 million for heart-mapping technology | By Mary Vanac
CLEVELAND, Ohio — CardioInsight Technologies Inc. raised $5.7 million in an ongoing funding round to help commercialize its heart-mapping technology, according to a regulatory filing.
The Cleveland company’s electrocardiograph... |
| 23.12.2009 | Smith & Nephew closes Nucryst buyout | The wound management division of Smith & Nephew (NYSE:SNN) closed its $21 million deal for Nucryst Pharmaceuticals Corp. (NASDAQ:NCST; TSX:NCS).
Smith & Nephew will use the Fort Saskatchewan, Canada-based company’s nanocrystalline s... |
| - | NC biotech strikes deal to launch new blood clotting bandage | For its 9th birthday, the North Carolina biotech Entegrion is giving itself a present: a product on the market.
The Research Triangle Park company has struck a licensing deal with a Boston-based medical device company to manufacture and mar... |
| - | CardioInsight Technologies closes $6M investment round for heart-mapping technology | CLEVELAND, Ohio — CardioInsight Technologies has closed its second funding round, raising $6 million from new and existing investors to speed up and expand testing and commercialization of its heart-mapping technology.
Existing investors Dr... |
| - | CardioInsight raises $5.7M for heart-mapping technology | CLEVELAND, Ohio — CardioInsight Technologies Inc. has raised $5.7 million in an ongoing funding round to help commercialize its heart-mapping technology, according to a regulatory filing.
The Cleveland company’s electrocardiographic mappin... |
| - | Smith & Nephew realignment plan targets growth in emerging markets | British orthopedic giant Smith & Nephew plc (NYSE:SNN) announced an ambitious plan to realign the entire company to focus growth on the emerging markets of Brazil, Russia, India and China, while creating a more streamlined operation in ... |
| - | Four barriers stifling medical device innovation | Smith & Nephew (NYSE:SNN) executive Mark Augusti takes time to occasionally talk to students about his experience in medical devices and his thoughts on the industry.
Often he’s asked if the industry that he’s made his career will be a ... |
| - | Smith & Nephew spins off N.C. biologics unit into joint venture Bioventus | Smith & Nephew‘s (NYSE:SNN) spinoff of its biologics and clinical therapies operation into a joint venture will keep the business at its present location in Durham, North Carolina.
But the unit, which will be majority owned by life scie... |
